The EGFR gene gives cells instructions for a surface protein that receives growth signals and helps control when cells grow, divide, and repair. In medicine, this gene is important because it helps regulate these signals, and if the pathway becomes too active, cells may keep multiplying when they should not. That can play a role in several cancers, especially some non-small cell lung cancers. Testing a tumor for EGFR variants can help clarify diagnosis and guide treatment choices.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the molecules that do the work inside cells. Others mainly help direct when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
EGFRGene function
What if the gene works
The EGFR gene helps cells sense growth signals from outside the cell. This supports normal cell growth, survival, and repair, especially in the skin, lungs, and lining of the gut.
Risk
What if the gene does not work
Changes in the EGFR gene can drive some tumors, especially non-small cell lung cancer. Rare inherited severe variants can also affect the skin and gut lining. Effects vary from milder to more disruptive variants.
Treatment
What does that mean for your treatment
Certain activating variants in the EGFR gene can make tumors more likely to respond to EGFR targeted medicines, especially osimertinib. The exact EGFR variant helps guide drug choice, because exon 20 insertion variants usually need different targeted drugs than the more common sensitizing variants.
Conditions associated with EGFR
Gene function
What if the gene works
Cells need steady instructions to know when to grow, divide, and replace worn out tissue. The EGFR gene helps manage these messages by making a receiver on the cell surface. This is part of how the EGFR gene helps cells grow and repair in a controlled way.
The EGFR gene makes a cell surface receiver that detects growth messages from nearby cells. When a signal arrives, it passes that message inward so the cell can respond.
EGFR activity helps cells know when it is time to grow and divide during normal tissue upkeep. This supports a balanced pattern of cell replacement in everyday life.
Many tissues use EGFR signals during normal renewal and surface repair. This is especially important in the skin and in the lining of organs.
EGFR messages can help guide how some cells develop into their usual working roles. This helps growing tissues build the right mix of cell types.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the EGFR gene can alter how strongly cells receive growth signals. Some variants keep the receptor switched on, while others change its shape, stability, or drug binding. This helps explain how EGFR gene variants affect cell signaling: effects can range from mild shifts in activity to more severe variants that sharply boost signaling or reduce it by disrupting folding or truncating the protein.
How variants are linked to conditions
Variants in the EGFR gene are best known for their link to non small cell lung cancer, especially lung adenocarcinoma. Some EGFR gene variants are also associated with glioblastoma and a smaller number of other cancers. Rare inherited changes in the EGFR gene have been linked to lung cancer running in families. In these cancer settings, an EGFR variant helps classify the condition, but it does not by itself predict exactly what will happen for one person.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, however, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For inherited EGFR changes, personal risk can be shaped by the exact variant and family history. Smoking and long-term exposure to secondhand smoke or other lung irritants can further raise the chance of lung cancer, while there is not enough evidence to say any specific lifestyle change removes the inherited risk.
Inheritance of EGFR variants
For inherited EGFR related conditions, the best established pattern is autosomal dominant. In practical terms, inheritance of EGFR gene variants means a parent who carries a disease associated variant can pass it to a son or daughter, and each child has a 50% chance of inheriting that same variant. Because the EGFR gene is on chromosome 7, this chance is the same for males and females.
What does my EGFR result mean for my family?
Some inherited EGFR changes linked to a family pattern of lung cancer can be passed down in a dominant way, which means close relatives may also carry the same change. In that situation, parents, brothers, sisters, and children can have a chance of sharing it. Many EGFR results found in a tumor are not inherited, though, so they usually do not mean family members are at risk.
Genetic information
Genetic testing
How you find out about variants
To find variants in the EGFR gene, EGFR genetic testing reads DNA from tumor tissue or sometimes a blood sample called a liquid biopsy. In lung cancer care, EGFR genetic testing helps show whether a variant is present and which one it is. A lab uses sequencing, a method that reads the gene's code, to report the result.
When should I consider getting a genetic test?
If you have non-small cell lung cancer, testing the tumor for changes in the EGFR gene can help guide treatment choices. Inherited EGFR testing is much less common, but it may be discussed when several close relatives have had lung cancer, especially if it developed at a younger age or without smoking.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
In some cancers, variants in the EGFR gene can help predict response to certain targeted medicines, especially EGFR inhibitors. This is because these drugs are designed to block signals from the EGFR pathway, and some gene changes make a tumor more likely to depend on that pathway. More broadly, genetic variation can influence how the body or a tumor responds to treatment, so the same medicine may work better for some people than for others. It can also affect how sensitive someone is to a drug and what side effects they may notice.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect their response to medications. It studies the relationship between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can help support more informed and individualized treatment decisions. If you want to read more about this topic, you can learn more in the LearnHub.
Drugs influenced by the EGFR gene
When should I seek medical advice?
If you are being treated for lung cancer or another cancer where tumor testing is part of care, talk with your doctor before starting or changing targeted treatment. Changes in the EGFR gene in the tumor can strongly affect whether certain cancer medicines are likely to help. Your cancer team can explain whether your EGFR result matters for your treatment plan.
History
EGFR became a major focus of cancer research after studies of epidermal growth factor in the 1970s helped reveal how cells receive growth signals. In 1986, Stanley Cohen received the Nobel Prize for earlier work on epidermal growth factor, which helped bring wider attention to the EGFR pathway. Initially understood only through visible traits, later recognized as tied to a specific gene, EGFR was soon linked to several cancers when researchers found that some tumors carried extra copies or overactive forms of it. From these first observations, research expanded steadily. By the early 2000s, EGFR testing had become especially important in lung cancer, as specific variants were found to predict response to targeted medicines. This marked a shift toward more personalized cancer care.